CLOV vs CVS vs MOH Stock Comparison

Clover Health Investments, Cvs Health and Molina Healthcare Prices as of Nov 13, 2026 Peers: Industry group
CVS CVS HEALTH Corp
$89.33 -1.2% 1M +12.7% 1Y
Market cap
$114.34B
P/E
10.4x
Revenue (TTM)
$420.61B
Div. yield
2.99%
Managed Care Healthcare
8 wins
MOH Molina Healthcare, Inc.
$209.62 +0.3% 1M +51.4% 1Y
Market cap
$10.90B
P/E
–
Revenue (TTM)
$44.13B
Div. yield
–
Managed Care Healthcare
1 win

Head to Head

11 decided of 12

Cvs Health leads on 8 of the 12 questions below (Cvs Health 8, Clover Health Investments 2, Molina Healthcare 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCLOVCVSMOHLeader
Larger companyMarket capitalisation $2.65B $114.34B $10.90B CVS
Cheaper on earningsLower P/E, profitable companies only 211.8x 10.4x -223.6x CVS
Cheaper on forward earningsLower price / next fiscal year consensus EPS 82.7x 10.2x 41.0x CVS
Faster revenue growthRevenue growth, trailing twelve months +54.5% +6.7% -0.9% CLOV
More profitableNet margin, trailing twelve months 0.5% 2.6% -0.1% CVS
Better return on capitalReturn on invested capital — 9.7% 2.2% CVS
Less leveragedLower net debt / EBITDA — 2.3x -14.4x MOH
Higher dividend yieldTrailing dividend yield — 2.99% — –
Better 1-year returnPrice return, last 12 months +100.8% +12.7% +51.4% CLOV
Better 5-year returnAnnualised price return, 5 years -7.1%/yr -1.0%/yr -7.7%/yr CVS
Less volatileAnnualised volatility, 1 year 59.0% 35.1% 52.5% CVS
Higher overall scoreMean of the five percentile scores vs peers 57/100 72/100 36/100 CVS

Percentile Scorecard

CLOVCVSMOH

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCLOVCVSMOH
Valuation 39 #17 of 27 100 #1 of 27 42 #16 of 27
Growth 96 #2 of 26 80 #6 of 26 4 #25 of 26
Profitability 44 #15 of 26 84 #5 of 26 32 #18 of 26
Financial Health 84 #5 of 26 24 #20 of 26 64 #10 of 26
Shareholder Returns 24 #14 of 18 71 #6 of 18 –
Overall 57 72 36
  • CLOV ranked among 27 companies in Healthcare Payers and Distributors
  • CVS ranked among 27 companies in Healthcare Payers and Distributors
  • MOH ranked among 27 companies in Healthcare Payers and Distributors

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCLOVCVSMOHSPY
1 month +3.5%-1.2%+0.3% -2.0%
3 months +7.8%-8.1%-1.3% -2.8%
6 months +42.9%-6.8%+13.3% +2.0%
Year to date +111.1%+12.6%+20.8% +10.6%
1 year +100.8%+12.7%+51.4% +12.2%
3 years +391.1%+30.4%-42.2% +68.1%
3 years, per year +70.0%+9.3%-16.7% +18.9%
5 years -30.7%-5.0%-33.1% +61.4%
5 years, per year -7.1%-1.0%-7.7% +10.1%
10 years —+19.0%+341.0% +248.5%
10 years, per year —+1.8%+16.0% +13.3%

Risk

MeasureCLOVCVSMOHSPY
Volatility, 1Y 59.0%35.1%52.5% 13.6%
Downside volatility, 1Y 48.9%38.8%57.9% 13.9%
Beta vs S&P 500, 1Y 1.11-0.05-0.01 1.00
Return / volatility, 1Y 1.710.360.98 0.90
Max drawdown, 5Y -91.8%-60.5%-70.8% -25.4%
From 52-week high -8.3%-19.2%-13.7% -3.2%
52-week high $5.41$110.55$242.88 $779.14
52-week low $1.70$70.08$122.65 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCLOVCVSMOH
P/E now vs peer median 211.8xmedian 25.2x 10.4xmedian 25.2x -223.6xmedian 25.2x
P/S now vs peer median 1.0xmedian 0.4x 0.3xmedian 0.4x 0.2xmedian 0.4x
EV/EBITDA now vs peer median 170.0xmedian 14.5x 8.2xmedian 14.5x 18.3xmedian 14.5x
P/FCF now vs peer median 20.0xmedian 16.5x 7.3xmedian 16.5x 45.8xmedian 16.5x
P/B now vs peer median 6.8xmedian 2.7x 1.4xmedian 2.7x 2.6xmedian 2.7x
PEG now vs peer median 7.85median 1.72 1.22median 1.72 8.22median 1.72

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCLOVCVSMOH
Revenue $2.74B $420.61B $44.13B
Gross profit $516.60M $186.06B $5.56B
Operating income $12.45M $15.06B $172.00M
Net income $12.45M $11.09B -$48.00M
Free cash flow $132.28M $15.57B $238.00M
EPS (diluted) $0.02 $8.55 $-0.93
Cash & equivalents $268.07M $11.74B $4.48B
Total debt – $60.68B $3.77B
Shares (diluted) 557.48M 1.29B 51.50M
Enterprise value $1.87B $63.29B -$24.10B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCLOVCVSMOH
P/E 211.8x 10.4x -223.6x
P/FCF 20.0x 7.3x 45.8x
P/Operating cash flow 19.6x 6.1x 32.9x
P/S 1.0x 0.3x 0.2x
P/B 6.8x 1.4x 2.6x
P/Tangible book 6.8x 2.0x 2.6x
EV/EBITDA 170.0x 8.2x 18.3x
EV/EBIT 186.3x 10.6x 35.4x
EV/Revenue 0.8x 0.4x 0.1x
EV/FCF 17.5x 10.3x 25.6x
EV/Operating cash flow 17.1x 8.6x 18.4x
PEG (3Y EPS CAGR) 7.85 1.22 8.22

Growth

14 metrics
MetricCLOVCVSMOH
Revenue growth (1Y) 54.5% 6.7% -0.9%
Revenue CAGR (3Y) 92.5% 6.5% 9.9%
Gross profit growth (1Y) 37.5% 5.3% -10.2%
Gross profit CAGR (3Y) 22.8% 10.9% 3.3%
Operating income growth (1Y) 121.6% 206.4% -87.0%
Operating income CAGR (3Y) 27.6% 2.4% -49.8%
Net income growth (1Y) 121.3% 2,369% -105.4%
Net income CAGR (3Y) 27.1% 8.6% -27.1%
EPS growth (1Y) 119.6% 2,213% -105.5%
EPS CAGR (3Y) 27.0% 8.5% -27.2%
Operating cash flow growth (1Y) 395.0% 105.4% 171.8%
Operating cash flow CAGR (3Y) 39.0% 9.9% -46.3%
Free cash flow growth (1Y) 377.7% 147.4% 141.5%
Free cash flow CAGR (3Y) 38.5% 11.3% -51.1%

Profitability

14 metrics
MetricCLOVCVSMOH
Gross margin 18.9% 44.2% 12.6%
EBITDA margin 0.5% 4.7% 0.8%
Operating margin 0.5% 3.6% 0.4%
Pretax margin 0.5% 2.9% -0.1%
Net margin 0.5% 2.6% -0.1%
FCF margin 4.8% 3.7% 0.5%
Operating cash flow margin 4.9% 4.4% 0.8%
Return on equity 2.9% 13.8% -1.2%
Return on assets 1.5% 4.3% -0.3%
Return on invested capital – 9.7% 2.2%
Return on capital employed 3.2% 9.2% 2.0%
Asset turnover 3.7x 1.6x 2.8x
Cash conversion (OCF / net income) 10.9x 1.7x -6.9x
Stock comp / revenue 2.0% 0.2% 0.2%

Financial Health

11 metrics
MetricCLOVCVSMOH
Debt / assets – 23.5% 24.1%
Debt / equity – 0.8x 0.9x
Net debt / EBITDA – 2.3x -14.4x
Debt / FCF – 3.9x 15.8x
Liabilities / assets 48.1% 68.7% 73.5%
Equity / assets 51.9% 31.3% 26.5%
Interest coverage – 4.9x 0.8x
Current ratio 1.5x 0.9x 1.7x
Quick ratio 0.9x 0.8x 1.6x
Cash ratio 0.9x 0.2x 1.2x
Altman Z-score 4.23 2.51 4.15

Shareholder Returns

7 metrics
MetricCLOVCVSMOH
Dividend yield – 3.0% –
Net buyback yield 0.0% -0.4% –
Shareholder yield 0.0% 2.6% –
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCLOVCVSMOH
Forward P/E 82.7xFY2026 10.2xFY2026 41.0xFY2026
EPS, next fiscal year $0.06FY2026 $8.80FY2026 $5.11FY2026
EPS growth, next FY +50.0%FY2026 +30.4%FY2026 -53.7%FY2026
EPS growth, the year after +83.3% +1.1% +93.0%
Revenue, next fiscal year $2.83BFY2026 $431.16BFY2026 $41.59BFY2026
Revenue growth, next FY +47.2%FY2026 +7.2%FY2026 -8.5%FY2026
Revenue growth, the year after +34.4% -5.3% +20.4%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCLOVCVSMOH
Held by institutions 27.6% 89.1% 100.0%
Institutions holding 227 2,074 600
Change in shares held, QoQ +14.4% +3.5% +1.2%
Institutions buying 124 1,103 364
Institutions selling 55 733 170
Buyers to sellers 2.25 1.50 2.14

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CLOVCVSMOH
CLOV 1.00 0.16 0.17
CVS 0.16 1.00 0.21
MOH 0.17 0.21 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, CLOV, CVS and MOH?

Cvs Health (CVS) is the largest by market capitalisation: Clover Health Investments (CLOV) $2.65B, Cvs Health (CVS) $114.34B, Molina Healthcare (MOH) $10.90B.

Which stock is cheaper, CLOV, CVS and MOH?

Cvs Health (CVS) trades on the lowest price-to-earnings ratio (Clover Health Investments (CLOV) 211.8x, Cvs Health (CVS) 10.4x, Molina Healthcare (MOH) -223.6x). On next year's consensus earnings, Cvs Health (CVS) is cheapest (Clover Health Investments (CLOV) 82.7x, Cvs Health (CVS) 10.2x, Molina Healthcare (MOH) 41.0x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Clover Health Investments (CLOV) grew revenue fastest over the trailing twelve months: Clover Health Investments (CLOV) +54.5%, Cvs Health (CVS) +6.7%, Molina Healthcare (MOH) -0.9%.

Which company is more profitable?

Cvs Health (CVS) has the highest net margin (Clover Health Investments (CLOV) 0.5%, Cvs Health (CVS) 2.6%, Molina Healthcare (MOH) -0.1%). On return on invested capital, Cvs Health (CVS) leads (Cvs Health (CVS) 9.7%, Molina Healthcare (MOH) 2.2%).

Which stock has performed better?

Over the past year Clover Health Investments (CLOV) returned the most: Clover Health Investments (CLOV) +100.8%, Cvs Health (CVS) +12.7%, Molina Healthcare (MOH) +51.4%. Over five years, Cvs Health (CVS) compounded fastest (Clover Health Investments (CLOV) -7.1%/yr, Cvs Health (CVS) -1.0%/yr, Molina Healthcare (MOH) -7.7%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Cvs Health (CVS) 2.99%. Clover Health Investments (CLOV) and Molina Healthcare (MOH) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Cvs Health (CVS) has been the steadiest (Clover Health Investments (CLOV) 59.0%, Cvs Health (CVS) 35.1%, Molina Healthcare (MOH) 52.5%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, CLOV, CVS and MOH?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Cvs Health (CVS) leads on 8. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.